New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Colucci
W S
WS
Wright
R F
RF
Braunwald
E
E
D000262:Adenylyl Cyclases / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D002118:Calcium / Q000502:physiology; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000494:pharmacology / Q000502:physiology; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000031:analogs & derivatives / Q000494:pharmacology; D004361:Drug Tolerance; D005934:Glucagon / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy*; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000032:analysis; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000032:analysis; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D002316:Cardiotonic Agents; D010726:Phosphodiesterase Inhibitors; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D013566:Sympathomimetics; D014970:Xanthines; C008514:methylxanthine; D004280:Dobutamine; D007980:Levodopa; D006632:Histamine; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium; D004298:Dopamine